These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1399697)

  • 1. 4-[123I]iodospiperone as a ligand for dopamine DA receptors: in vitro and in vivo experiments in a rat model.
    Van der Krogt JA; Pauwels EK; Van Doremalen PA; Wijnhoven G; Reiffers S; Van Valkenburg CF; Buruma OJ
    Int J Rad Appl Instrum B; 1992 Oct; 19(7):759-63. PubMed ID: 1399697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioiodinated 2'-iodospiperone: a new radioligand for in vivo dopamine receptor study.
    Saji H; Nakatsuka I; Shiba K; Tokui T; Horiuchi K; Yoshitake A; Torizuka K; Yokoyama A
    Life Sci; 1987 Oct; 41(17):1999-2006. PubMed ID: 3669906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of radioiodinated butyrophenones as radiotracer for dopamine receptor study.
    Nakatsuka I; Saji H; Shiba K; Shimizu H; Okuno M; Yoshitake A; Yokoyama A
    Life Sci; 1987 Oct; 41(17):1989-97. PubMed ID: 2959832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 125I-Spiperone: a novel ligand for D2 dopamine receptors.
    Gundlach AL; Largent BL; Snyder SH
    Life Sci; 1984 Nov; 35(19):1981-8. PubMed ID: 6149442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo binding of spiperone and N-methylspiperone to dopaminergic and serotonergic sites in the rat brain: multiple modeling and implications for PET scanning.
    Swart JA; van der Werf JF; Wiegman T; Paans AM; Vaalburg W; Korf J
    J Cereb Blood Flow Metab; 1990 May; 10(3):297-306. PubMed ID: 1970341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo D2-dopamine receptor binding with [123I]S(-) iodobenzamide ([123I]IBZM) in rat and human brain.
    Verhoeff NP; Bobeldijk M; Feenstra MG; Boer GJ; Maas MA; Erdtsieck-Ernste E; de Bruin K; van Royen EA
    Int J Rad Appl Instrum B; 1991; 18(8):837-46. PubMed ID: 1839302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP; Wooten GF
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]spiperone binds selectively to rat striatal D2 dopamine receptors in vivo: a kinetic and pharmacological analysis.
    Leslie CA; Bennett JP
    Brain Res; 1987 Mar; 407(2):253-62. PubMed ID: 2952221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 77Br-p-bromospiperone: a ligand for in vivo labelling of dopamine receptors.
    Owen F; Poulter M; Mashal RD; Crow TJ; Veall N; Zanelli GD
    Life Sci; 1983 Aug; 33(8):765-8. PubMed ID: 6888192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The binding of [3H]N-(chloroethyl)-norapomorphine to rat striatal membranes.
    Kilpatrick GJ; Jenner P; Marsden CD
    Eur J Pharmacol; 1984 Dec; 107(1):71-8. PubMed ID: 6084599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photoaffinity labeling of the D2-dopamine receptor using a novel high affinity radioiodinated probe.
    Amlaiky N; Caron MG
    J Biol Chem; 1985 Feb; 260(4):1983-6. PubMed ID: 2579064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors.
    Kessler RM; Ansari MS; Schmidt DE; de Paulis T; Clanton JA; Innis R; al-Tikriti M; Manning RG; Gillespie D
    Life Sci; 1991; 49(8):617-28. PubMed ID: 1830917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S; Nahorski SR
    Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of the apparent affinity of the striatal dopamine receptors for the radioligand[3H]spiperone [( 3H]spiroperidol).
    Hruska RE
    J Neurosci Res; 1984; 12(4):571-81. PubMed ID: 6512888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogeny of dopaminergic function in the rat midbrain tegmentum, corpus striatum and frontal cortex.
    Noisin EL; Thomas WE
    Brain Res; 1988 Jun; 469(1-2):241-52. PubMed ID: 3401800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ; Tarazi FI; Creese I
    J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo [3H]spiperone binding to the rat hippocampal formation: involvement of dopamine receptors.
    Bischoff S; Bittiger H; Krauss J
    Eur J Pharmacol; 1980 Dec; 68(3):305-15. PubMed ID: 7202494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous dopamine (DA) modulates [3H]spiperone binding in vivo in rat brain.
    Bischoff S; Krauss J; Grunenwald C; Gunst F; Heinrich M; Schaub M; Stöcklin K; Vassout A; Waldmeier P; Maître L
    J Recept Res; 1991; 11(1-4):163-75. PubMed ID: 1886078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.